Synthesis and antidepressant and anxiolytic activity of derivatives of pyrazolo[4,3-c]pyridine and 4-phenylhydrazinonicotinic acids
The synthesis of compounds effective in the treatment of anxiety—depression disorders is described. It is established that 4,6-dimethyl-2-(4-chlorophenyl)-2,3-dihydro-1 H -pyrazolo[4,3- c ]pyridine-3-one hydrochloride ( IVa ) possesses combined antidepressant and anxiolytic properties. Advantages of...
Gespeichert in:
Veröffentlicht in: | Pharmaceutical chemistry journal 2012-04, Vol.46 (1), p.15-19 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 19 |
---|---|
container_issue | 1 |
container_start_page | 15 |
container_title | Pharmaceutical chemistry journal |
container_volume | 46 |
creator | Zhmurenko, L. A. Molodavkin, G. M. Voronina, T. A. Lezina, V. P. |
description | The synthesis of compounds effective in the treatment of anxiety—depression disorders is described. It is established that 4,6-dimethyl-2-(4-chlorophenyl)-2,3-dihydro-1
H
-pyrazolo[4,3-
c
]pyridine-3-one hydrochloride (
IVa
) possesses combined antidepressant and anxiolytic properties. Advantages of
IVa
are low toxicity and the absence of side effects typical of antidepressants (elevated anxiety) and benzodiazepine anxiolytics (myorelaxant and sedative action). |
doi_str_mv | 10.1007/s11094-012-0726-z |
format | Article |
fullrecord | <record><control><sourceid>gale_cross</sourceid><recordid>TN_cdi_gale_infotracmisc_A359334756</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A359334756</galeid><sourcerecordid>A359334756</sourcerecordid><originalsourceid>FETCH-LOGICAL-c524t-78fe7b722899ef313743c1d5d2a81a1c0f8102f2d907d59cbe18394f5fd1ef443</originalsourceid><addsrcrecordid>eNp9kU9rXCEUxaW00GnaD9DdQLc18aovPpch9B8EsmgLhVLE6DVzwxsd9DX0zbZfvE4mm0IpInou53dQDmOvQZyCEOasAQiruQDJhZHnfP-ErWAwiluh4ClbCWGBwyC-PWcvWrsTolNKrtjvz0ueN9iorX2Ofc8UcVextX59HP2iMi0zhbUPM93TvKxLWkesdO-7xnaQu6X6fZnKd_1W8fCjS4qU8SFB890G8zJtlthNlEumUGbKD4kU20v2LPmp4avH84R9ff_uy-VHfnX94dPlxRUPg9QzN2NCc2OkHK3FpEAZrQLEIUo_gocg0ghCJhmtMHGw4QZhVFanIUXApLU6YW-Oubd-Qkc5lbn6sKUW3IUarFLaDOfddfoPV18Rt_3dGRP1-V8AHIFQS2sVk9tV2vq6OBDuUI47luN6Oe5Qjtt3Rh6Z1r35Fqu7Kz9r7r__D_QH70OU2g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Synthesis and antidepressant and anxiolytic activity of derivatives of pyrazolo[4,3-c]pyridine and 4-phenylhydrazinonicotinic acids</title><source>SpringerNature Journals</source><creator>Zhmurenko, L. A. ; Molodavkin, G. M. ; Voronina, T. A. ; Lezina, V. P.</creator><creatorcontrib>Zhmurenko, L. A. ; Molodavkin, G. M. ; Voronina, T. A. ; Lezina, V. P.</creatorcontrib><description>The synthesis of compounds effective in the treatment of anxiety—depression disorders is described. It is established that 4,6-dimethyl-2-(4-chlorophenyl)-2,3-dihydro-1
H
-pyrazolo[4,3-
c
]pyridine-3-one hydrochloride (
IVa
) possesses combined antidepressant and anxiolytic properties. Advantages of
IVa
are low toxicity and the absence of side effects typical of antidepressants (elevated anxiety) and benzodiazepine anxiolytics (myorelaxant and sedative action).</description><identifier>ISSN: 0091-150X</identifier><identifier>EISSN: 1573-9031</identifier><identifier>DOI: 10.1007/s11094-012-0726-z</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Alkaloids ; Antianxiety agents ; Antidepressants ; Depression, Mental ; Esters ; Medicine ; Organic Chemistry ; Pharmacology/Toxicology ; Pharmacy ; Pyridine</subject><ispartof>Pharmaceutical chemistry journal, 2012-04, Vol.46 (1), p.15-19</ispartof><rights>Springer Science+Business Media, Inc. 2012</rights><rights>COPYRIGHT 2012 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c524t-78fe7b722899ef313743c1d5d2a81a1c0f8102f2d907d59cbe18394f5fd1ef443</citedby><cites>FETCH-LOGICAL-c524t-78fe7b722899ef313743c1d5d2a81a1c0f8102f2d907d59cbe18394f5fd1ef443</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11094-012-0726-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11094-012-0726-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids></links><search><creatorcontrib>Zhmurenko, L. A.</creatorcontrib><creatorcontrib>Molodavkin, G. M.</creatorcontrib><creatorcontrib>Voronina, T. A.</creatorcontrib><creatorcontrib>Lezina, V. P.</creatorcontrib><title>Synthesis and antidepressant and anxiolytic activity of derivatives of pyrazolo[4,3-c]pyridine and 4-phenylhydrazinonicotinic acids</title><title>Pharmaceutical chemistry journal</title><addtitle>Pharm Chem J</addtitle><description>The synthesis of compounds effective in the treatment of anxiety—depression disorders is described. It is established that 4,6-dimethyl-2-(4-chlorophenyl)-2,3-dihydro-1
H
-pyrazolo[4,3-
c
]pyridine-3-one hydrochloride (
IVa
) possesses combined antidepressant and anxiolytic properties. Advantages of
IVa
are low toxicity and the absence of side effects typical of antidepressants (elevated anxiety) and benzodiazepine anxiolytics (myorelaxant and sedative action).</description><subject>Alkaloids</subject><subject>Antianxiety agents</subject><subject>Antidepressants</subject><subject>Depression, Mental</subject><subject>Esters</subject><subject>Medicine</subject><subject>Organic Chemistry</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacy</subject><subject>Pyridine</subject><issn>0091-150X</issn><issn>1573-9031</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp9kU9rXCEUxaW00GnaD9DdQLc18aovPpch9B8EsmgLhVLE6DVzwxsd9DX0zbZfvE4mm0IpInou53dQDmOvQZyCEOasAQiruQDJhZHnfP-ErWAwiluh4ClbCWGBwyC-PWcvWrsTolNKrtjvz0ueN9iorX2Ofc8UcVextX59HP2iMi0zhbUPM93TvKxLWkesdO-7xnaQu6X6fZnKd_1W8fCjS4qU8SFB890G8zJtlthNlEumUGbKD4kU20v2LPmp4avH84R9ff_uy-VHfnX94dPlxRUPg9QzN2NCc2OkHK3FpEAZrQLEIUo_gocg0ghCJhmtMHGw4QZhVFanIUXApLU6YW-Oubd-Qkc5lbn6sKUW3IUarFLaDOfddfoPV18Rt_3dGRP1-V8AHIFQS2sVk9tV2vq6OBDuUI47luN6Oe5Qjtt3Rh6Z1r35Fqu7Kz9r7r__D_QH70OU2g</recordid><startdate>20120401</startdate><enddate>20120401</enddate><creator>Zhmurenko, L. A.</creator><creator>Molodavkin, G. M.</creator><creator>Voronina, T. A.</creator><creator>Lezina, V. P.</creator><general>Springer US</general><general>Springer</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20120401</creationdate><title>Synthesis and antidepressant and anxiolytic activity of derivatives of pyrazolo[4,3-c]pyridine and 4-phenylhydrazinonicotinic acids</title><author>Zhmurenko, L. A. ; Molodavkin, G. M. ; Voronina, T. A. ; Lezina, V. P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c524t-78fe7b722899ef313743c1d5d2a81a1c0f8102f2d907d59cbe18394f5fd1ef443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Alkaloids</topic><topic>Antianxiety agents</topic><topic>Antidepressants</topic><topic>Depression, Mental</topic><topic>Esters</topic><topic>Medicine</topic><topic>Organic Chemistry</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacy</topic><topic>Pyridine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhmurenko, L. A.</creatorcontrib><creatorcontrib>Molodavkin, G. M.</creatorcontrib><creatorcontrib>Voronina, T. A.</creatorcontrib><creatorcontrib>Lezina, V. P.</creatorcontrib><collection>CrossRef</collection><jtitle>Pharmaceutical chemistry journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhmurenko, L. A.</au><au>Molodavkin, G. M.</au><au>Voronina, T. A.</au><au>Lezina, V. P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and antidepressant and anxiolytic activity of derivatives of pyrazolo[4,3-c]pyridine and 4-phenylhydrazinonicotinic acids</atitle><jtitle>Pharmaceutical chemistry journal</jtitle><stitle>Pharm Chem J</stitle><date>2012-04-01</date><risdate>2012</risdate><volume>46</volume><issue>1</issue><spage>15</spage><epage>19</epage><pages>15-19</pages><issn>0091-150X</issn><eissn>1573-9031</eissn><abstract>The synthesis of compounds effective in the treatment of anxiety—depression disorders is described. It is established that 4,6-dimethyl-2-(4-chlorophenyl)-2,3-dihydro-1
H
-pyrazolo[4,3-
c
]pyridine-3-one hydrochloride (
IVa
) possesses combined antidepressant and anxiolytic properties. Advantages of
IVa
are low toxicity and the absence of side effects typical of antidepressants (elevated anxiety) and benzodiazepine anxiolytics (myorelaxant and sedative action).</abstract><cop>Boston</cop><pub>Springer US</pub><doi>10.1007/s11094-012-0726-z</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0091-150X |
ispartof | Pharmaceutical chemistry journal, 2012-04, Vol.46 (1), p.15-19 |
issn | 0091-150X 1573-9031 |
language | eng |
recordid | cdi_gale_infotracmisc_A359334756 |
source | SpringerNature Journals |
subjects | Alkaloids Antianxiety agents Antidepressants Depression, Mental Esters Medicine Organic Chemistry Pharmacology/Toxicology Pharmacy Pyridine |
title | Synthesis and antidepressant and anxiolytic activity of derivatives of pyrazolo[4,3-c]pyridine and 4-phenylhydrazinonicotinic acids |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T19%3A17%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20antidepressant%20and%20anxiolytic%20activity%20of%20derivatives%20of%20pyrazolo%5B4,3-c%5Dpyridine%20and%204-phenylhydrazinonicotinic%20acids&rft.jtitle=Pharmaceutical%20chemistry%20journal&rft.au=Zhmurenko,%20L.%20A.&rft.date=2012-04-01&rft.volume=46&rft.issue=1&rft.spage=15&rft.epage=19&rft.pages=15-19&rft.issn=0091-150X&rft.eissn=1573-9031&rft_id=info:doi/10.1007/s11094-012-0726-z&rft_dat=%3Cgale_cross%3EA359334756%3C/gale_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A359334756&rfr_iscdi=true |